We are live on
!
Find out more
DA
DCF Advisers Portfolio holdings
AUM
$375M
1-Year Est. Return
72.65%
This Fund
S&P 500
This Quarter
Est. Return
-7.16%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$168M
AUM Growth
-$60.4M
(-26%)
Cap. Flow
-$28.4M
Cap. Flow
% of AUM
-16.91%
Top 10 Holdings %
Top 10 Hldgs %
50.46%
Holding
90
New
22
Increased
16
Reduced
21
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.54M |
| 2 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$2.46M |
| 3 |
Netflix
NFLX
|
+$1.73M |
| 4 |
KraneShares CSI China Internet ETF
KWEB
|
+$1.72M |
| 5 |
Energy Transfer Partners
ET
|
+$1.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.09M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$1.99M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$1.81M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$1.3M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.38% |
| 2 | Technology | 13.36% |
| 3 | Communication Services | 7.77% |
| 4 | Financials | 5.3% |
| 5 | Consumer Discretionary | 2.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
1
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $11.8M | 7.02% |
206,588
-31,912
| -13% | -$1.81M |
|
|
2
AbbVie
ABBV
$443B
| $11.5M | 6.85% |
75,100
-13,650
| -15% | -$2.09M |
|
3
Micron Technology
MU
$930B
| $9.67M | 5.76% |
175,000
+7,500
| +4% | +$509K |
|
4
PUT
Invesco QQQ Trust
QQQ
$453B
| $9.53M | 5.67% |
34,000
-70,000
| -67% | -$21.7M |
|
5
argenx
ARGX
$53.4B
| $9.47M | 5.64% |
25,000
| – | – |
|
|
6
Alphabet (Google) Class C
GOOG
$4.36T
| $8.42M | 5.02% |
77,000
-10,000
| -11% | -$1.18M |
|
|
7
Regeneron Pharmaceuticals
REGN
$78.5B
| $7.51M | 4.47% |
12,700
-2,000
| -14% | -$1.3M |
|
8
Xencor
XNCR
$1.5B
| $6.84M | 4.07% |
249,800
-7,200
| -3% | -$178K |
|
9
SPDR Gold Trust
GLD
$131B
| $5.47M | 3.26% |
32,500
+2,500
| +8% | +$437K |
|
10
Bank of America
BAC
$435B
| $4.53M | 2.7% |
145,500
| – | – |
|
|
IMPL
11
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $4.09M | 2.43% |
438,566
+71,508
| +19% | +$522K |
|
|
12
Apple
AAPL
$4.54T
| $4M | 2.38% |
29,250
+16,750
| +134% | +$2.54M |
|
13
Altimmune
ALT
$552M
| $3.92M | 2.34% |
335,180
+19,180
| +6% | +$118K |
|
14
Citigroup
C
$222B
| $3.68M | 2.19% |
80,000
+10,000
| +14% | +$500K |
|
15
PUT
Vanguard S&P 500 ETF
VOO
$979B
| $3.47M | 2.07% |
+10,000
| New | +$3.77M |
|
16
iShares Gold Trust
IAU
$62.9B
| $3.43M | 2.04% |
100,000
| – | – |
|
17
Incyte
INCY
$24.2B
| $3.34M | 1.99% |
44,000
-1,500
| -3% | -$114K |
|
18
VanEck Gold Miners ETF
GDX
$22.7B
| $3.15M | 1.88% |
115,000
+12,500
| +12% | +$422K |
|
19
Oracle
ORCL
$374B
| $2.73M | 1.62% |
39,000
| – | – |
|
20
Eli Lilly
LLY
$1.02T
| $2.67M | 1.59% |
8,250
-2,100
| -20% | -$630K |
|
|
SGEN
21
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.65M | 1.58% |
15,000
| – | – |
|
22
General Motors
GM
$80.4B
| $2.38M | 1.42% |
75,000
-5,000
| -6% | -$188K |
|
|
23
Energy Transfer Partners
ET
$70.1B
| $2.3M | 1.37% |
230,900
+89,900
| +64% | +$1.01M |
|
24
Advanced Micro Devices
AMD
$776B
| $2.29M | 1.37% |
30,000
| – | – |
|
25
Turning Point Brands
TPB
$1.45B
| $2.24M | 1.33% |
82,436
-21,240
| -20% | -$623K |
|
Similar funds
JIC
CIM
AIM
MWM
RCP
HPM
CAG
LWMNY
DCF Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, DCF Advisers held 90 positions worth $168M, down 26% from $228M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
DCF Advisers withdrew a net $28.4M in Q2 2022, closing 14 positions and reducing 21 holdings. Its most notable exit was Illinois Tool Works, an estimated $1.06M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 35% a quarter earlier, followed by Technology and Communication Services.
Against the trend, DCF Advisers opened a new position in State Street SPDR S&P Oil & Gas Exploration & Production ETF worth $2.09M.
- DCF Advisers's largest Q2 2022 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 17,500 shares worth $2.09M.
- DCF Advisers added most to Apple in Q2 2022, an estimated $2.54M increase.
- DCF Advisers's biggest Q2 2022 reduction was AbbVie, cutting an estimated $2.09M.
- DCF Advisers fully exited Illinois Tool Works in Q2 2022, selling an estimated $1.06M.
- DCF Advisers's ten largest holdings make up 50% of its $168M portfolio in Q2 2022.
- DCF Advisers opened 22 new positions and closed 14 in Q2 2022.
- DCF Advisers's portfolio value fell 26% quarter-over-quarter to $168M.
Based on DCF Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.